Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dialyzability and Pharmacokinetics of Amenamevir in Hemodialysis Patients
jRCT2080224180Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Amenamevir, sponsored by Maruho Co., Ltd. Primary endpoint: Pharmacokinetics and dialyzability of amenamevir. Started Dec 2018; status: completed.
02
Drugs
Amenamevir
Beyond the preview
Go deeper on jRCT2080224180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224180.